Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/45766
metadata.artigo.dc.title: COVID-19 vaccine and boosted immunity: nothing ad interim to do?
metadata.artigo.dc.creator: Roncati, Luca
Vadalà, Maria
Corazzari, Veronica
Palmieri, Beniamino
metadata.artigo.dc.subject: COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Corynebacterium parvum (C. parvum)
Bacillus Calmette-Guérin (BCG)
Hyaluronic acid
Cluster of differentiation 44 (CD44)
Vaccine
metadata.artigo.dc.publisher: Elsevier
metadata.artigo.dc.date.issued: Nov-2020
metadata.artigo.dc.identifier.citation: RONCATI, L. et al. COVID-19 vaccine and boosted immunity: nothing ad interim to do? Vaccine, [S.l.], v. 38, n. 48, p. 7581-7584, Nov. 2020.
metadata.artigo.dc.description.abstract: Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2.
metadata.artigo.dc.identifier.uri: https://www.sciencedirect.com/science/article/pii/S0264410X20313037
http://repositorio.ufla.br/jspui/handle/1/45766
metadata.artigo.dc.language: en_US
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.